Biodegradable Polycaprolactone (PCL) Nanosphere Encapsulating Superoxide Dismutase and Catalase Enzymes

被引:0
作者
Sushant Singh
Abhay Narayan Singh
Anil Verma
Vikash Kumar Dubey
机构
[1] Indian Institute of Technology Guwahati,Centre for Environment
[2] Indian Institute of Technology Guwahati,Department of Biotechnology
[3] Indian Institute of Technology Guwahati,Department of Chemical Engineering
来源
Applied Biochemistry and Biotechnology | 2013年 / 171卷
关键词
Catalase; Nanosphere; Oxidative stress; Polycaprolactone; Superoxide dismutase;
D O I
暂无
中图分类号
学科分类号
摘要
Biodegradable polycaprolactone (PCL) nanosphere encapsulating superoxide dismutase (SOD) and catalase (CAT) were successfully synthesized using double emulsion (w/o/w) solvent evaporation technique. Characterization of the nanosphere using dynamic light scattering, field emission scanning electron microscope, and Fourier transform infrared spectroscopy revealed a spherical-shaped nanosphere in a size range of 812 ± 64 nm with moderate protein encapsulation efficiency of 55.42 ± 3.7 % and high in vitro protein release. Human skin HaCat cells were used for analyzing antioxidative properties of SOD- and CAT-encapsulated PCL nanospheres. Oxidative stress condition in HaCat cells was optimized with exposure to hydrogen peroxide (H2O2; 1 mM) as external stress factor and verified through reactive oxygen species (ROS) analysis using H2DCFDA dye. PCL nanosphere encapsulating SOD and CAT together indicated better antioxidative defense against H2O2-induced oxidative stress in human skin HaCat cells in comparison to PCL encapsulating either SOD or CAT alone as well as against direct supplement of SOD and CAT protein solution. Increase in HaCat cells SOD and CAT activities after treatment hints toward uptake of PCL nanosphere into the human skin HaCat cells. The result signifies the role of PCL-encapsulating SOD and CAT nanosphere in alleviating oxidative stress.
引用
收藏
页码:1545 / 1558
页数:13
相关论文
共 105 条
  • [1] Brickers DR(2006)undefined J. Invest. Derma. 126 2565-2575
  • [2] Athar M(2003)undefined Br Med Bull 68 129-142
  • [3] English JSC(1997)undefined Exp. Physio. 82 291-295
  • [4] Dawe RS(2002)undefined Indian J Exp Biol 40 656-667
  • [5] Ferguson J(2002)undefined Neuroscientist 8 323-334
  • [6] Sies H(2012)undefined Vector Borne Zoonotic Dis 12 953-960
  • [7] Athar M(2012)undefined Eur J Pharm Biopharm 82 485-490
  • [8] Maier CM(2013)undefined Eur J Pharm Biopharm 83 156-167
  • [9] Chan PH(2008)undefined Appl Biochem Biotechnol 151 565-577
  • [10] Shukla AK(2005)undefined J Control Release 107 65-77